Search bioRxiv⌕ Search

Biology subjects

Sawhney, M.

Publications and source records attributed to Sawhney, M..

2 recordsLinked to original sources

Deep Learning Enabled Label-free Cell Force Computation in Deformable Fibrous Environments

Cells move within tissues by pulling on and reshaping their fibrous surroundings. Measuring the associated forces has been a fundamental challenge in cell biology. Here, we develop deep-learning-enabled live-cell fiber-force microscopy (DLFM), which computes forces produced by living cells in real time as they interact with tissue-like fiber networks. DLFM combines basic phase microscopy with novel deep learning to simultaneously track cell movement and fiber deformation without disruptive fluorescent labels or chemical modifications. This allowed us to measure forces in real-time situations that were previously impossible to study, revealing an intricate mechanical landscape: cells generate ten-fold changes in force as they change shape during migration, create force-dipoles during cell-cell interactions, and dramatically alter their force patterns during stem cell differentiation. Through integrated experiments and mathematical modeling, we discovered that cells in fibrous environments form force-generating adhesions throughout their body, strikingly different from the edge-only adhesions seen in traditional petri dish experiments. Results clarify cytoskeletal pathways by which cells adapt force-generating machinery to navigate the fibrous architecture of tissues.

biophysics↗

Pancreatic tumor organoids for modeling in vivo drug response and discovering clinically-actionable biomarkers

Patient-derived models are transforming translational cancer research. It is not clear if the emergence of patient-derived organoid (PDO) models can extend the utility of the widely used patient-derived xenograft (PDX). In addition, the utility of PDO models for serum biomarker discovery is not known. Here, we demonstrate that PDO models recapitulate the genomics, cell biology, glycomics and drug responses observed in PDX models. Furthermore, we demonstrate the applicability of PDO models for identification of N-glycans that are enriched in the glycome of pancreatic ductal adenocarcinoma (PDAC). Surprisingly, among all the glycans observed in PDX and PDOs, a core set of 57 N-glycans represent 50-94% of the relative abundance of all N-glycans detected, suggesting that only a subset of glycans dominate the cell surface landscape in PDAC. In addition, we outline a tumor organoid-based pipeline to identify surface proteins in extracellular vesicles (EV) from media supernatant of PDO cultures. When combined with the affinity-based validation platform, the EV surface proteins discovered in PDOs are effective in differentiating patients with PDAC from those with benign pancreatitis in the clinic, identifying PDO as powerful discovery platform for serum biomarkers. Thus, PDOs extend the utility of the archival collections of PDX models for translational research and function as a powerful platform for identification of clinically-actionable biomarkers in patients blood. Significance statementTumor organoids extend the utility of PDX models as platforms for investigating drug response, glycosylation changes and function as new platforms for discovering blood-based biomarkers

cancer biology↗